| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.22 | 0.0009 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.001 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.001 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.18 | 0.001 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.001 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.18 | 0.001 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.002 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |